Anthrax (Bacillus anthracis)

Anthrax is an acute, highly fatal infectious disease caused by the spore-forming bacterium Bacillus anthracis, affecting virtually all warm-blooded animals but particularly devastating to cattle, sheep, goats, and horses. This ancient disease has been recognized since biblical times and remains one of the most significant veterinary and public health concerns worldwide due to its extreme lethality, environmental persistence, and zoonotic potential. The disease is characterized by sudden death, often with minimal or no premonitory clinical signs, making it one of the most dramatic and economically impactful conditions in livestock agriculture. Anthrax spores can persist in contaminated soil for decades, creating endemic areas where disease recurs periodically.

Anthrax occurs worldwide but is most prevalent in agricultural regions with alkaline, calcium-rich soils that favor spore survival, particularly in parts of Africa, Asia, southern Europe, and the Americas. In endemic areas, the disease tends to occur seasonally, often following periods of drought or flooding that expose buried spores or concentrate animals on contaminated ground. All ruminant livestock species are highly susceptible, with sheep and cattle showing the highest mortality rates, often approaching 100 percent in unvaccinated populations. Horses are also highly susceptible, while pigs demonstrate somewhat greater resistance due to their different immune response. Outbreaks can affect multiple species simultaneously on a single premises, and wildlife populations may also be involved in endemic cycles.

The economic and welfare impact of anthrax extends far beyond the immediate loss of affected animals. A single outbreak can devastate a herd within hours to days, with no opportunity for salvage of affected animals due to disease severity and regulatory restrictions. Carcass disposal requirements are stringent and expensive, typically requiring complete incineration or deep burial to prevent environmental contamination. Movement restrictions imposed during outbreak investigations disrupt normal farm operations and market access. The zoonotic nature of anthrax creates occupational health risks for farmers, veterinarians, and others handling infected animals or contaminated materials. Public health implications may result in broader regulatory responses affecting entire agricultural communities.

Anthrax is a reportable or notifiable disease in virtually all countries, meaning that any suspected case must be immediately reported to governmental veterinary authorities. This reporting requirement reflects the disease's significance for animal health, public health, and potentially national security given historical concerns about biological weapons. Immediate diagnosis and response are critical for limiting outbreak extent, and regulatory involvement typically includes epidemiological investigation, quarantine of affected premises, emergency vaccination of at-risk animals, and oversight of proper carcass disposal. Early recognition of anthrax is essential, though the peracute nature of the disease often means animals are found dead before treatment can be attempted. Vaccination remains the cornerstone of prevention in endemic areas.

The causative agent of anthrax is Bacillus anthracis, a large, gram-positive, rod-shaped, spore-forming bacterium that produces potent toxins responsible for the disease's devastating effects. This organism exists in two forms: the vegetative bacterial cell and the dormant endospore. Vegetative cells multiply rapidly within the infected host but are relatively fragile in the environment, while endospores can survive for decades in soil under appropriate conditions, retaining full virulence and creating persistent reservoirs for future infection. The bacterium produces three proteins that combine to form two toxins, lethal toxin and edema toxin, which disrupt host cellular functions and immune responses, leading to the characteristic massive tissue damage and death seen in anthrax cases.

There is no genetic predisposition to anthrax in the sense of inherited susceptibility within species; rather, susceptibility varies among species and is determined by factors including innate immune characteristics and physiological differences. Cattle and sheep are extremely susceptible, with very low infectious doses capable of initiating fatal disease. Horses are similarly susceptible. Goats demonstrate high susceptibility but may show slightly longer clinical courses in some cases. Pigs are more resistant than ruminants and equids, typically requiring larger doses for infection and sometimes developing more localized disease manifestations. Individual animal factors such as immune status, concurrent illness, and nutritional condition may influence clinical outcomes but do not prevent infection in exposed susceptible species.

Environmental factors play a crucial role in anthrax epidemiology and transmission. The disease occurs most frequently in areas with alkaline, calcareous soils with pH above 6.0, which favor spore survival. Periods of drought followed by rain can concentrate spores in low-lying areas where animals water or graze, triggering outbreaks. Flooding can redistribute spores from burial sites or endemic foci to new areas. Construction, excavation, or soil disturbance can unearth spores from old burial sites. Seasonal patterns often reflect interactions between weather, animal grazing behavior, and spore availability, with summer and fall typically showing highest incidence in temperate regions. Climate change may be altering traditional endemic patterns and expanding areas of risk.

Risk factors for anthrax infection relate primarily to exposure opportunities. Grazing on contaminated pastures represents the most common infection route, with animals ingesting spores while eating vegetation or soil. Access to low-lying areas, pond edges, and drainage areas where spores may concentrate increases risk. Supplemental feeding with contaminated bone meal or meat and bone meal, though now prohibited in most jurisdictions, historically caused outbreaks. Introduction of animals from endemic areas to naive herds can bring infection. Contact with contaminated hides, wool, or other animal products poses risks to both animals and humans. Areas with historical anthrax occurrence, old burial sites, or former tannery locations represent ongoing risk zones. Lack of vaccination in endemic areas is the primary manageable risk factor.

The pathophysiology of anthrax infection begins when spores are ingested, inhaled, or enter through skin wounds or insect bites. Following ingestion, spores are taken up by macrophages and transported to regional lymph nodes where germination occurs. The vegetative bacteria multiply explosively, rapidly overwhelming local immune defenses and entering the bloodstream to cause massive septicemia. Bacterial toxins damage vascular endothelium, cause fluid extravasation, and disrupt organ function throughout the body. The spleen becomes massively enlarged and engorged with blood, giving rise to the term splenic fever. Terminal bacteremia reaches extraordinary concentrations, with blood appearing dark and failing to clot properly. Death results from toxemia, shock, and multi-organ failure. In animals that die from anthrax, the body rapidly becomes a factory for spore production as vegetative bacteria exposed to air during decomposition or necropsy sporulate, contaminating the immediate environment.

Early warning signs of anthrax are frequently absent or extremely brief due to the peracute nature of the disease in highly susceptible species. In cattle and sheep, the most common presentation is sudden death without observed premonitory illness, with animals found dead that appeared completely normal at the previous observation. When clinical signs are observed, they may include very brief periods of fever, excitement, disorientation, or muscle tremors lasting only minutes to a few hours before collapse and death. Some animals may show brief episodes of difficult breathing, staggering, or convulsions immediately before death. The rapid progression from apparent health to death is characteristic and should immediately raise suspicion of anthrax, particularly in endemic areas or when multiple animals are affected.

Clinical presentation varies somewhat among livestock species based on susceptibility and disease form. In cattle, the peracute form predominates with death occurring within one to three hours of first clinical signs, though occasional subacute cases may show illness for up to 48 hours with high fever, depression, weakness, and labored breathing before death. Sheep typically show the most rapid progression, often dying without any observed signs. Horses may show a slightly longer clinical course of 48 to 96 hours with fever, colic, severe depression, swelling in the throat and lower body regions, and dysentery before death. Pigs more commonly develop localized pharyngeal and cervical swelling due to oral exposure, though systemic disease occurs. Goats generally resemble sheep in presentation but may occasionally show slightly longer courses.

Behavioral changes, when observable, include sudden separation from the herd, loss of appetite, cessation of rumination, reluctance to move, and apparent confusion or disorientation. Affected animals may stand with heads lowered, legs splayed, or appear to be straining. Some animals become aggressive or hyperexcitable before progressing to depression and collapse. Convulsions or paddling movements may occur terminally. Animals that were aggressively eating or behaving normally may collapse and die within minutes, a presentation virtually pathognomonic for anthrax when it occurs in susceptible species in endemic areas.

Physical signs observed in anthrax cases include extremely high fever up to 107 degrees Fahrenheit in the brief period before death when measurements are possible. The mucous membranes may appear congested or cyanotic. Edematous swelling of the throat, brisket, and perineal regions may develop in cases with longer clinical courses. Bloody discharges from the nose, mouth, and anus are characteristic terminal or post-mortem findings, resulting from failure of blood clotting mechanisms. The blood itself is dark and tarry in appearance and fails to clot properly. In pigs with localized pharyngeal anthrax, severe swelling of the throat may cause respiratory distress and difficult swallowing before systemic signs develop. Cutaneous anthrax with localized skin lesions is rare in livestock but may occur at sites of insect bites or wounds.

Symptom progression in the rare cases where a clinical course is observable moves rapidly from initial fever and malaise to severe systemic illness and death. Animals initially appearing only mildly ill can deteriorate dramatically within hours. Fever may spike suddenly before dropping terminally as circulatory collapse occurs. Breathing becomes increasingly labored and agonal. Muscle tremors, convulsions, and terminal opisthotonus may occur. Once animals become recumbent, death follows rapidly. The entire observed clinical course from first signs to death typically spans less than 24 hours in cattle and may be less than one hour in sheep. Any animal surviving beyond 48 hours either has a different condition or represents an unusual anthrax presentation requiring diagnostic confirmation.

Emergency symptoms requiring immediate response include any sudden death or peracute illness in livestock, particularly when multiple animals are affected, in known endemic areas, or during seasonal risk periods. Discovery of dead animals with bloody discharges from body orifices demands immediate anthrax consideration. Any rapidly fatal illness in cattle, sheep, or horses should trigger investigation before carcass manipulation occurs. Animals showing high fever, bloody diarrhea, difficulty breathing, or sudden collapse require immediate veterinary attention and should be handled with appropriate zoonotic disease precautions. It is critical to avoid performing necropsy on animals suspected of anthrax, as opening the carcass promotes sporulation and environmental contamination. The appropriate response to suspected anthrax is immediate notification of veterinary authorities while preventing any carcass disturbance.

Clinical examination of anthrax is complicated by the peracute nature of the disease, which typically presents as sudden death rather than a diagnosable clinical syndrome. When live animals with suspected anthrax are examined, findings are nonspecific and may include high fever, rapid heart rate, rapid respiration, dark congested mucous membranes, and signs of shock. Post-mortem examination without carcass opening may reveal failure of rigor mortis, rapid bloating, bloody discharge from body orifices, and dark blood that fails to clot. The carcass should not be opened if anthrax is suspected, as exposure to air triggers sporulation of vegetative bacteria, massively contaminating the environment. If inadvertent necropsy has been performed, characteristic findings include failure of blood clotting, an enlarged and softened spleen with dark tarry blood, widespread hemorrhages throughout tissues, and fluid accumulation in body cavities.

Diagnostic testing for anthrax confirmation requires specialized laboratory procedures and appropriate biosafety precautions. Blood smears from peripheral vessels or a small incision can be collected with minimal environmental risk and stained to reveal the characteristic large, square-ended, gram-positive rods occurring singly or in short chains, often surrounded by a capsule visible with special stains. Bacterial culture definitively identifies Bacillus anthracis but must be performed in laboratories with appropriate containment facilities due to the extreme hazard of this organism. Polymerase chain reaction testing provides rapid confirmation by detecting specific genetic sequences of B. anthracis. Serological tests can detect antibodies in surviving animals or demonstrate prior exposure but are less useful for acute diagnosis. Direct fluorescent antibody testing on blood smears provides rapid preliminary identification in equipped laboratories.

Differential diagnosis for sudden death in livestock encompasses numerous conditions that must be distinguished from anthrax. Clostridial diseases including blackleg, malignant edema, and enterotoxemia cause sudden death but typically show gas production in affected tissues and specific lesion patterns. Lightning strike and electrocution cause sudden death without the hemorrhagic features of anthrax. Bloat produces death with marked abdominal distension but without bloody discharges. Acute poisoning from various plant or chemical toxins may cause rapid death. Hypomagnesemia causes sudden death in cattle but typically in specific circumstances of lush pasture and lactation stress. Snakebite and acute allergic reactions occur but are usually individual animal events. The key distinguishing feature of anthrax is the combination of sudden death with failure of blood clotting and bloody discharges, though laboratory confirmation is essential.

Herd-level diagnostics in anthrax situations focus on rapid outbreak characterization and source identification to limit further losses and environmental contamination. Epidemiological investigation examines animal movements, pasture use, feed sources, and temporal pattern of deaths to identify potential exposure sources. Environmental sampling of soil from suspected contaminated areas can confirm spore presence. Serological testing of surviving herd members may identify subclinical exposure and guide vaccination decisions. Testing of feed materials for spore contamination is indicated if feedborne exposure is suspected. Historical investigation of the premises for prior anthrax occurrence, old burial sites, or other contamination sources provides context. Geographic information system mapping of cases helps identify spatial patterns suggesting point source versus ongoing exposure.

Emergency and immediate treatment for anthrax, when attempted at all, requires extreme urgency given the rapid progression of the disease. Any animal showing early signs of possible anthrax, particularly during an ongoing outbreak or in an endemic area, should receive immediate high-dose antibiotic therapy without waiting for diagnostic confirmation. Penicillin is the antibiotic of choice and should be administered intravenously at high doses, with some protocols recommending up to 22,000 international units per kilogram body weight initially. Treatment must begin within hours of clinical onset to have any chance of success, and even with immediate therapy, mortality remains very high in animals with established disease. Severely affected animals with signs of circulatory collapse should be humanely euthanized rather than subjected to futile treatment attempts.

Medical management of anthrax cases that survive the initial critical period involves continued antimicrobial therapy for extended periods. Intravenous penicillin should be continued until clinical stabilization, transitioning to intramuscular administration for a total treatment course of at least five to seven days. Alternative antibiotics including oxytetracycline, enrofloxacin, or florfenicol may be used if penicillin is contraindicated or unavailable. Supportive therapy including intravenous fluid administration to combat shock, anti-inflammatory medications, and nursing care supports survival in the rare cases that respond to treatment. It is critical to observe appropriate withdrawal times for all medications used in food-producing animals, though animals recovered from anthrax may be subject to regulatory restrictions regarding slaughter. Veterinary guidance is essential for all aspects of anthrax treatment.

Surgical intervention has no role in anthrax management. Incision of edematous swellings or attempted abscess drainage in pharyngeal anthrax cases would release massive numbers of bacteria into the environment, creating extreme contamination and zoonotic risk. Necropsy of animals that have died from anthrax is contraindicated except under highly controlled conditions in specialized facilities, as opening the carcass promotes sporulation and environmental contamination that can persist for decades. Any surgical instruments, equipment, or materials that have contacted anthrax-infected tissues require specialized decontamination procedures and may need to be destroyed. The focus in anthrax cases is on medical treatment of surviving animals and proper disposal of carcasses without environmental contamination.

Supportive care for animals undergoing treatment includes complete rest in clean, isolated facilities away from other livestock. Provision of palatable feed and water supports animals that may be anorexic or too weak to compete at communal feeding areas. Temperature regulation through shelter from heat or cold reduces metabolic stress during recovery. Careful monitoring for treatment response or deterioration guides ongoing management decisions. Animals that survive the acute phase may require extended convalescence before returning to normal production. Strict isolation prevents potential transmission to unvaccinated herd mates during the period of bacterial shedding.

Herd treatment protocols during anthrax outbreaks focus on protecting exposed but not yet clinically affected animals. Mass antibiotic treatment of all animals in an affected herd or group may be implemented as an emergency measure while vaccination response develops. Simultaneously, emergency vaccination with the Sterne spore vaccine should be administered to all cattle, sheep, and other susceptible species on the affected premises and potentially on neighboring premises. A two-week interval between antibiotic treatment and vaccination is traditionally recommended to avoid antibiotic interference with vaccine response, but during active outbreaks, both may be administered with the understanding that revaccination may be needed. Movement restrictions prevent potentially infected animals from leaving the premises and spreading disease.

Treatment decisions in anthrax cases are heavily influenced by regulatory requirements, public health considerations, and practical constraints. Because anthrax is a reportable disease, all cases must be reported to veterinary authorities who will oversee response efforts. Treatment attempts may be prohibited or discouraged by regulatory officials who prioritize containment over saving individual animals. The zoonotic risk of anthrax mandates that human safety take precedence over animal treatment, and personnel handling infected animals must use appropriate protective equipment and follow biosafety protocols. Economic considerations are secondary to regulatory compliance and public health protection. The emotional impact of sudden, multiple losses can be devastating for producers, and psychological support may be needed alongside the veterinary response.

Recovery timeline for the rare animals that survive anthrax infection depends on disease severity, treatment timing, and individual response. Animals treated very early in infection before severe systemic involvement may show clinical improvement within 24 to 48 hours of initiating appropriate antibiotic therapy. However, the systemic damage caused by bacterial toxins may result in prolonged weakness, reduced appetite, and impaired function lasting days to weeks after infection is controlled. Complete return to normal health and productivity typically requires several weeks of convalescence, and some animals may suffer permanent damage to organ systems affected by toxemia. The survival rate even with treatment is low, and most animals diagnosed with clinical anthrax will not survive.

Post-treatment care and monitoring of surviving animals requires continued antimicrobial therapy to ensure complete elimination of infection and prevent relapse. Regular veterinary assessment monitors for complications or deterioration. Temperature monitoring identifies any recurrence of fever suggesting persistent infection. Observation of appetite, attitude, and strength guides supportive care intensity. Blood work may be performed to assess organ function and recovery. Animals that have recovered from anthrax may shed bacteria in secretions for variable periods and should remain isolated from susceptible animals until veterinary clearance is obtained. Documentation of treatment, recovery progress, and eventual outcome supports both clinical management and any regulatory requirements.

Prognosis for anthrax is grave in all cases and depends critically on timing of intervention. Animals found already moribund or collapsed have essentially no chance of survival regardless of treatment intensity. Animals treated at the earliest recognition of clinical signs, before significant toxemia has developed, may have survival rates approaching 30 to 50 percent with intensive therapy, though data is limited due to disease rarity and the difficulty of identifying cases early enough for treatment. Animals that survive the first 48 to 72 hours of treatment have improving prognosis, though complications may still prove fatal. Long-term prognosis for survivors is generally good if no permanent organ damage has occurred, though they may be subject to regulatory restrictions on marketing.

Return to production considerations for anthrax survivors involve both animal welfare and regulatory compliance. Physical recovery must be complete before animals resume normal production activities such as breeding, gestation, lactation, or fattening. Withdrawal times for all medications used during treatment must be observed before any products enter the food chain. Regulatory authorities may impose additional requirements or restrictions on animals that have recovered from anthrax, potentially including permanent exclusion from the food supply or requirements for documented disease-free status. The marketing value of recovered animals may be reduced due to regulatory issues or buyer concerns. Individual operations must balance the cost of continued care against the realistic value of recovered animals in making management decisions.

Vaccination protocols form the cornerstone of anthrax prevention in endemic areas and are highly effective when properly implemented. The Sterne strain spore vaccine, a non-encapsulated live spore vaccine, is the standard immunization for livestock worldwide and provides reliable protection when administered according to established protocols. Initial vaccination should be performed annually in endemic areas, with timing approximately two to four weeks before the historical risk season to allow protective immunity to develop. In areas with year-round risk or following an outbreak, more frequent vaccination may be recommended. Young animals should receive their first vaccination at three to six months of age, with a booster dose four to six weeks later for optimal protection. Adult animals previously unvaccinated require the same two-dose initial series. Annual revaccination is essential to maintain protection, as immunity wanes over time.

Biosecurity measures for anthrax prevention focus on limiting exposure to environmental spore reservoirs. Knowledge of local anthrax history and endemic areas guides pasture management decisions, with heavily contaminated sites potentially requiring permanent exclusion from grazing. Fencing to prevent livestock access to old burial sites, former tannery locations, or known contaminated areas provides physical barriers to exposure. Avoiding low-lying areas that may accumulate spores following flooding reduces risk. Preventing livestock access to carcasses of wild animals or domestic animals that have died from unknown causes eliminates a potential infection source. Restricting use of potentially contaminated water sources during high-risk periods may be prudent in endemic areas. Imported feed, particularly protein supplements from endemic regions, should be evaluated for potential contamination risk.

Nutritional prevention is not directly applicable to anthrax since the disease is caused by an environmental pathogen rather than nutritional deficiency. However, maintaining animals in good nutritional condition and overall health supports optimal immune function, potentially improving vaccine response and nonspecific disease resistance. Adequate nutrition supports robust immune response to vaccination. Avoidance of nutritional deficiencies that might impair immune function is prudent general practice. Feed security to prevent contamination of stored feeds with soil or environmental materials provides indirect protection. Bone meal and meat and bone meal feeding is prohibited in most jurisdictions and should never be practiced, eliminating historical feedborne transmission routes.

Management practices supporting anthrax prevention include regular surveillance for unexplained deaths, prompt investigation of any sudden livestock mortality, and maintaining awareness of disease risk in the area. Observation of animals for early signs of illness enables rare opportunities for early treatment. Proper carcass disposal of animals dying from any cause prevents potential environmental contamination and removes food sources that might attract scavengers capable of spreading infection. Record keeping of vaccination status, death losses, and any disease occurrence supports effective management and regulatory compliance. Communication with neighboring operations about disease activity enables coordinated response. Consultation with veterinary professionals about regional risk assessment and prevention strategies optimizes program effectiveness.

Quarantine and testing protocols are critical components of anthrax outbreak response and ongoing prevention. Following any confirmed anthrax case, regulatory authorities will impose quarantine on affected premises, restricting all animal movement until the outbreak is controlled and environmental decontamination is complete. Quarantine duration varies by jurisdiction but typically extends for at least 30 days after the last case and completion of required interventions. Introduction of animals from endemic areas or premises with recent anthrax history should be avoided or accompanied by documentation of vaccination status. Testing of animals prior to purchase from high-risk areas may be considered. Environmental testing of pastures in question helps guide grazing management decisions. Slaughter surveillance programs in endemic regions support ongoing detection of infection in the livestock population.

Daily management and monitoring in areas where anthrax is a concern requires heightened surveillance compared to disease-free regions. Livestock should be observed at least once daily, with more frequent observation during high-risk seasons or following environmental conditions known to increase anthrax exposure. Observation should note any animals separated from the group, showing reduced appetite, appearing lethargic, or exhibiting any signs of illness. Any unexplained death should be treated as potential anthrax until proven otherwise, with the carcass left undisturbed until veterinary assessment can occur. Training of all farm personnel on anthrax recognition, reporting procedures, and the critical importance of not disturbing suspect carcasses supports rapid appropriate response. Emergency contact information for veterinary services and regulatory authorities should be readily available.

Housing and environmental management decisions should incorporate anthrax risk assessment where relevant. Pasture selection should avoid known contaminated areas, sites of historical anthrax occurrence, and locations where environmental conditions may concentrate spores. Low-lying areas prone to flooding, pond edges, and drainage areas represent higher-risk grazing sites in endemic regions. Soil disturbance through construction, excavation, or agricultural activities in endemic areas may expose buried spores and should be approached with caution, potentially including protective vaccination of livestock before disturbance and avoidance of immediate grazing on disturbed soil. Water source management ensures livestock have access to clean water without need to access potentially contaminated ponds or low-lying areas. Carcass disposal planning ensures capacity for rapid, compliant disposal if deaths occur.

Herd health programs in anthrax-endemic areas must incorporate disease-specific protocols into routine management. Annual vaccination timing should be scheduled relative to historical risk seasons, allowing adequate time for immunity development before anticipated exposure periods. Vaccination records should document product used, date administered, and individual animal identification to demonstrate compliance and guide revaccination scheduling. Integration of anthrax prevention with other seasonal management activities such as breeding, weaning, or market preparation improves efficiency and compliance. Regular veterinary consultation ensures protocols remain current with evolving recommendations and regulatory requirements. Discussion of anthrax risk and prevention should occur during any herd health planning meetings.

Record keeping and monitoring systems support both routine prevention and effective outbreak response. Vaccination records should be maintained in permanent, accessible format with sufficient detail to demonstrate program compliance to regulatory officials. Death loss records should document date, location, clinical observations, and diagnostic findings for any livestock mortality. Pasture use records help identify potential exposure patterns if cases occur. Feed purchase and storage records support traceback investigations if feedborne exposure is suspected. Geographic coordinates or mapping of grazing areas, water sources, and any known contamination sites aids in risk assessment and outbreak investigation. These records should be retained for extended periods given the potential for long-delayed disease emergence from environmental spore reservoirs.

Economic considerations for anthrax prevention programs include vaccination costs, management modifications, and potential losses from inadequate prevention. Annual vaccination costs are modest relative to the catastrophic losses possible from an outbreak in an unprotected herd. Pasture management restrictions may reduce available grazing area but protect against potentially operation-ending disease events. Insurance considerations should include understanding of coverage for anthrax losses, which may be limited or excluded in some policies, and documentation requirements for claim submission. The value of maintaining documented vaccination status includes regulatory compliance, facilitated animal movement, and reduced liability exposure. Investment in prevention is highly cost-effective compared to outbreak response costs, which may include animal losses, regulatory compliance expenses, environmental remediation, and potentially legal liability for any human exposures.

Anthrax susceptibility is determined primarily by species rather than breed, with essentially all breeds within susceptible species showing similar vulnerability to infection. Cattle of all breeds, including beef breeds such as Angus, Hereford, Charolais, and Brahman, and dairy breeds such as Holstein, Jersey, and Brown Swiss, are highly susceptible to anthrax and show similar disease presentation and outcomes when infected. No breed-specific resistance or susceptibility has been documented in cattle. Similarly, all sheep breeds from fine wool Merinos to meat breeds like Suffolk and Hampshire share high susceptibility. Goat breeds including dairy, meat, and fiber types are all vulnerable. The lack of breed variation in susceptibility means that prevention efforts must protect all animals equally regardless of genetic background.

Production type considerations relate more to management and exposure patterns than inherent susceptibility differences. Extensively managed cattle and sheep grazing large range areas may have higher environmental exposure to anthrax spores compared to intensively managed animals in confinement or improved pastures, particularly in endemic regions. Cow-calf operations using extensive rangeland in endemic areas represent high-risk situations requiring vigilant vaccination programs. Feedlot cattle with controlled environment and feed sources have reduced exposure risk but are not immune if spores are present in the environment or feed. Dairy cattle in confinement have limited environmental exposure but require vaccination in endemic regions. Breeding stock maintained long-term have cumulative exposure risk over their lifetimes. Young stock may be particularly vulnerable if vaccinated too early before maternal antibody waning or if left unprotected between weaning and first vaccination.

Genetic selection and testing for anthrax resistance are not currently practiced or available in livestock species. No genetic markers for anthrax resistance have been identified in cattle, sheep, or other susceptible livestock. The acute, usually fatal nature of anthrax infection means that natural selection pressure has not produced resistant populations despite the disease's long history. Some research has explored immunogenetic factors that might influence vaccine response or nonspecific resistance, but practical applications have not emerged. Given the effectiveness of existing vaccines and the environmental nature of exposure, genetic approaches to anthrax control are unlikely to become priorities for research or commercial application. All animals regardless of genetic background require vaccination for protection in endemic areas.

Commonly co-occurring conditions with anthrax relate primarily to the immediate outbreak situation rather than chronic disease associations. During anthrax outbreaks, concurrent nutritional stress, parasitism, or other diseases may be present in affected herds and can complicate assessment of at-risk animals. Secondary bacterial infections in animals surviving initial anthrax exposure may develop but are rare given the high acute mortality. Environmental co-exposures such as clostridial spores present in the same soil may create mixed infection scenarios, though this is uncommon. Stress from outbreak management including handling, vaccination, and movement restrictions may exacerbate other subclinical conditions in the herd. The focus during anthrax outbreaks appropriately remains on the primary disease rather than concurrent conditions.

Conditions with similar symptoms requiring differentiation from anthrax include numerous causes of sudden death in livestock. Clostridial diseases including blackleg, malignant edema, and enterotoxemia cause rapid death but typically show gas production in affected tissues and lack the hemorrhagic features of anthrax. Lightning strike produces sudden death, often of multiple animals grouped together during storms, without infectious disease features. Acute bloat causes death with dramatic abdominal distension but without bloody discharges. Acute lead poisoning, organophosphate toxicity, and various plant poisonings cause death with neurological signs. Hypomagnesemia causes sudden death in cattle on lush pasture. Acute heartwater, anaplasmosis, and babesiosis can cause rapid deterioration in endemic areas. The key distinguishing features of anthrax remain sudden death with failure of blood clotting and bloody discharges from body orifices, combined with the characteristic post-mortem appearance if necropsy is performed.

Complications and sequelae of anthrax primarily relate to environmental contamination rather than consequences in individual animals, since survivors are rare. The critical long-term complication is soil contamination with anthrax spores that may persist for decades and cause disease recurrence long after the initial outbreak. Improper carcass disposal creates persistent contamination foci. Spread of spores by scavengers, flooding, or human activities can extend contaminated areas. Zoonotic transmission to humans handling infected animals or contaminated materials represents a serious public health complication. Economic sequelae include prolonged quarantine, marketing restrictions, and reputational damage to affected operations. Psychological impact on producers who experience devastating losses can be significant and long-lasting.